Allyl isothiocyanate increases MRP1 function and expression in a human bronchial epithelial cell line
Dian-lei Wang1, Chen-yin Wang1, Yin Cao2
1Anhui University of Chinese Medicine, Hefei, Anhui 230038, China.
Oxidative Medicine and Cellular Longevity
|March 28, 2014
Summary
Allyl isothiocyanate (AITC) increases the expression and activity of multidrug resistance-associated protein 1 (MRP1) in human bronchial cells. This suggests AITC may offer therapeutic benefits for lung diseases.
Area of Science:
- Cell Biology
- Pharmacology
- Biochemistry
Background:
- Multidrug resistance-associated protein 1 (MRP1) is an ABC transporter crucial for lung cell protection against toxins.
- Understanding MRP1 regulation is vital for developing treatments for lung diseases.
Purpose of the Study:
- To investigate the effects of allyl isothiocyanate (AITC) on MRP1 expression and activity in human bronchial epithelial cells (16HBE14o-).
Main Methods:
- Real-time PCR and Western blotting were used to analyze MRP1 mRNA and protein levels.
- Functional flow cytometry assessed MRP1 transporter activity using carboxyfluorescein efflux.
Main Results:
- AITC significantly increased MRP1 mRNA and protein expression in a concentration-dependent manner.
- AITC enhanced MRP1-dependent carboxyfluorescein efflux, indicating increased transporter activity.
- Upregulation occurred at AITC concentrations ranging from 1-40 μM.
Conclusions:
- AITC effectively upregulates both the expression and activity of MRP1 in human bronchial epithelial cells.
- The findings suggest AITC holds potential therapeutic value for treating lung diseases by enhancing cellular defense mechanisms.
Related Concept Videos
Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40


